Comment on article Biosimilar infliximab in anti-TNF naïve IBD patients – 1-year clinical follow-up
CommentGastroent Hepatol 2017; 71(4): 323–324. doi:10.14735/amgh2017323
Literaturepdf Peter D. R. HigginsGastroent Hepatol 2017; 71(4): 323–324. doi:10.14735/amgh2017323
Literaturepdf Peter D. R. Higgins